U.S.-Australia Emerging Cancer Biomedical Technologies Workshop

这一努力将使2017年6月13日至15日在弗吉尼亚州阿灵顿举行的国际研讨会成为可能，届时工程师和科学家将齐聚一堂，讨论新兴的癌症生物医学技术。本次国际会议的首要目标是了解该领域的现状，特别是与以下主题相关的领域：生物光子学和成像、癌症检测、癌症治疗、组织工程、细胞治疗、药物输送、生物医学工程和多尺度建模。随着这些平台的发展，这次研讨会将增加我们对科学的理解，并成为产生巨大经济影响的催化剂。研讨会将探索和发展美国和澳大利亚参与者之间从基础到转化合作的前沿研究机会，同时也为国际癌症研究的未来制定战略。研讨会将限制在100人以内，并将重点关注适用于癌症检测、治疗和临床研究的尖端、新兴生物医学技术。这些合作会议将汇集研究人员、联邦科学家和公司，他们专注于以下领域：生物光子学、表观基因组学、基因组学、基因工程、蛋白质组学、纳米技术、组织工程、单细胞分析技术、成像技术、微流体、材料和微创技术。

PI: Davalos, Rafael V.Proposal #:1735665This effort will enable an international workshop from June 13-15, 2017 in Arlington, Virginia, bringing together engineers and scientists to discuss emerging cancer biomedical technologies. The overarching goal of this international meeting is to understand the status of the field, specifically relating to topical areas of: biophotonics and imaging, cancer detection, cancer treatment, tissue engineering, cell therapeutics, drug delivery, biomedical engineering, and multi-scale modeling. This workshop will increase our scientific understanding serve as a catalyst for a large economic impact as these platforms are developed. The workshop will explore and develop opportunities for cutting-edge research spanning basic to translational collaborations between U.S. and Australian participants while also strategizing a future for cancer research internationally. The workshop will be limited to less than 100 participants and will focus on cutting-edge, emerging biomedical technologies applicable to cancer detection, treatment, and clinical studies. The collaborative sessions will bring together researchers, federal scientists and companies specializing in topical areas such as: biophotonics, epigenomics, genomics, genetic engineering, proteomics, nanotechnology, tissue engineering, single cell analysis technologies, imaging technologies, microfluidics, materials, and minimally invasive technologies.